Paragon Genomics to present at Biotech Showcase™ 2020HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Paragon Genomics to present at Biotech Showcase™ 2020PR NewswireJanuary 7, 2020ReblogShareTweetShareHAYWARD, Calif., Jan. 7, 2020 /PRNewswire/ -- Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for  next-generation sequencing (NGS) and precision medicine, today announced that it will present at Biotech Showcase™ 2020, to be held January 13–15, 2020 at the Hilton San Francisco Union Square. Paragon Genomics CEO Tao Chen will give a corporate presentation and meet with investors.Date: Tuesday, January 14, 2020Presentation Time: 1:45 pm PSTRoom: Yosemite C (Ballroom Level)Tao Chen commented, "During the past year Paragon Genomics launched important new products for our growing customer base and recorded substantial growth in product sales in both the U.S. and China. Our CleanPlex® technology has the potential to make NGS-based genomic analyses across a wide variety of applications faster, easier, more accurate, more economical and more feasible. Our clients have successfully applied our technologies to applications such as tumor profiling, inherited disease testing, reproductive health, drug discovery, single cell analysis and agrigenomics. We anticipate robust expansion in 2020 and look forward to sharing our exciting story with early stage life science investors in San Francisco next week."Paragon Genomics' CleanPlex is a proprietary, ultra-high multiplexed NGS target enrichment technology featuring an innovative PCR background cleaning chemistry that allows tens of thousands of amplicons to be multiplexed in a single reaction pool, allowing a large number of targets to be interrogated in a single assay. The CleanPlex technology is available as ready-to-use panels or as customized assays designed and optimized using the company's advanced panel design algorithm. Investors interested in scheduling a meeting with Paragon Genomics leadership in San Francisco should contact investment@paragongenomics.com. Investors interested in attending Biotech Showcase can visit informaconnect.com/biotech-showcase/ for more information.About Paragon GenomicsParagon Genomics (paragongenomics.com) is a leader in amplicon-based target enrichment and library preparation solutions to accelerate the development of next-generation sequencing (NGS)-based assays for research and clinical testing. The company designs and manufactures high performance and ultra-multiplexed amplicon NGS library preparation products for analyzing difficult, clinically relevant samples. It strives to be the NGS assay partner of choice for research and clinical NGS labs and make custom NGS assays easily available to a broad range of users. Privately held Paragon Genomics is located in Hayward, California. Contacts:
Corporate:
Media:
Paragon Genomics
Barbara Lindheim
Tao Chen
BLL Partners for Paragon Genomics
CEO
blindheim@bllbiopartners.com
tao@paragongenomics.com
(917) 355-9234
CisionMoreView original content:http://www.prnewswire.com/news-releases/paragon-genomics-to-present-at-biotech-showcase-2020-300982501.htmlSOURCE Paragon Genomics, Inc.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance VideoCoronavirus will wipe out corporate profit growth in 2020 and may trigger recession: Goldman SachsYahoo Finance